You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in patients with metastatic colorectal cancer (mCRC)
Contributor:
Garcia Alfonso, P.;
Chaves, M.;
Muñoz Martin, A.;
Salud Salvia, A.;
Vilchez, R.;
Yuste, A.;
Gravalos Castro, C.;
Queralt Merino, B.;
Gonzalez Flores, E.;
Lopez Ladron, A.;
Losa, F.;
Oltra Ferrando, A.;
Gomez Reina, M. J.;
Campos, J. M.;
Aranda, E.
imprint:
American Society of Clinical Oncology (ASCO), 2011